Skip to main content

Stephens Inc

SEC CIK
0000757657
Latest filing
Jul 29, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Stephens Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
831
Value
$517.9K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of REGN by Stephens Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026831$517.9K<0.1%−56−6.3%ReducedHolders
Q1 2026887$685.7K<0.1%+357+67.4%AddedHolders
Q4 2025530$409.4K<0.1%−11−2.0%ReducedHolders
Q3 2025541$304.4K<0.1%−207−27.7%ReducedHolders
Q2 2025748$392.8K<0.1%−145−16.2%ReducedHolders
Q1 2025893$566.4K<0.1%−55−5.8%ReducedHolders
Q4 2024948$675.3K<0.1%−6−0.6%ReducedHolders
Q3 2024954$1.00M<0.1%−1−0.1%ReducedHolders
Q2 2024955$1.00M<0.1%+42+4.6%AddedHolders
Q1 2024913$878.8K<0.1%+192+26.6%AddedHolders
Q4 2023721$633.2K<0.1%+84+13.2%AddedHolders
Q3 2023637$524.2K<0.1%−5−0.8%ReducedHolders
Q2 2023642$461.3K<0.1%−5−0.8%ReducedHolders
Q1 2023647$531.6K<0.1%−72−10.0%ReducedHolders
Q4 2022719$518.8K<0.1%00.0%UnchangedHolders
Q3 2022719$495.0K<0.1%−10−1.4%ReducedHolders
Q2 2022729$431.0K<0.1%−3−0.4%ReducedHolders
Q1 2022732$511.0K<0.1%00.0%UnchangedHolders
Q4 2021732$462.0K<0.1%−5−0.7%ReducedHolders
Q3 2021737$446.0K<0.1%−7−0.9%ReducedHolders
Q2 2021744$416.0K<0.1%−100−11.8%ReducedHolders
Q1 2021844$399.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.